Bonraybio Co., Ltd. (TPE:6955)
Taiwan · Delayed Price · Currency is TWD 165.00
-3.00 (-1.79%)
At close: Apr 17, 2026
Bonraybio Market Cap
Bonraybio has a market cap or net worth of 4.09 billion as of April 20, 2026. Its market cap has increased by 44.63% in one year.
Market Cap
4.09B
Enterprise Value
3.54B
Revenue
306.31M
Ranking
n/a
PE Ratio
40.05
Stock Price
165.00
Market Cap Chart
Since July 25, 2023, Bonraybio's market cap has increased from 1.48B to 4.09B, an increase of 177.20%. That is a compound annual growth rate of 45.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 4.09B | 11.49% |
| Dec 31, 2025 | 3.67B | 24.12% |
| Dec 31, 2024 | 2.96B | 101.25% |
| Dec 29, 2023 | 1.47B | -0.46% |
| Jul 25, 2023 | 1.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Optoelectronics | 6.72B |
| Hi-Clearance | 6.05B |
| Delta Asia International | 6.00B |
| WeLeader Biomedical | 3.05B |
| Medimaging Integrated Solution | 2.89B |
| Dynamic Medical Technologies | 2.55B |
| A Plus Biotechnology | 2.49B |
| Applied BioCode | 2.35B |